Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	microfilament motor activity	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO5C	1.15e-10	38	131	8	GO:0000146
GeneOntologyMolecularFunction	cytoskeletal motor activity	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	8.35e-08	118	131	9	GO:0003774
GeneOntologyMolecularFunction	actin filament binding	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SYNE1 SPTB MYO18A MYO5C	3.09e-07	227	131	11	GO:0051015
GeneOntologyMolecularFunction	calmodulin binding	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MKNK2 MYO5C TJP1 PCNT	3.52e-07	230	131	11	GO:0005516
GeneOntologyMolecularFunction	actin binding	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SYNE1 SPTB MYO18A MYRIP MIB2 MYO5C DST PRKCE	6.02e-07	479	131	15	GO:0003779
GeneOntologyMolecularFunction	cytoskeletal protein binding	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 GIT1 SYNE1 SPTB NUMA1 MYO18A PACSIN3 MYRIP MIB2 MYO5C DST FARP1 PRKCE RP1	3.18e-05	1099	131	20	GO:0008092
GeneOntologyBiologicalProcess	muscle filament sliding	MYH2 MYH3 MYH4 MYH8	2.07e-06	15	132	4	GO:0030049
GeneOntologyBiologicalProcess	actin-myosin filament sliding	MYH2 MYH3 MYH4 MYH8	4.57e-06	18	132	4	GO:0033275
GeneOntologyBiologicalProcess	actin filament-based movement	MYH2 MYH3 MYH4 MYH8 MYH10 MYRIP MYO5C KCNE4	6.46e-06	153	132	8	GO:0030048
GeneOntologyCellularComponent	myosin filament	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A	2.02e-12	25	132	8	GO:0032982
GeneOntologyCellularComponent	myosin II complex	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A	5.70e-12	28	132	8	GO:0016460
GeneOntologyCellularComponent	myosin complex	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	1.17e-10	59	132	9	GO:0016459
GeneOntologyCellularComponent	muscle myosin complex	MYH1 MYH2 MYH3 MYH4 MYH8 MYH11	4.30e-10	16	132	6	GO:0005859
GeneOntologyCellularComponent	contractile muscle fiber	MYH1 MYH2 MYH3 MYH4 MYH8 MYH11 SYNE1 STK11 DST HRC AHNAK2	2.37e-06	290	132	11	GO:0043292
GeneOntologyCellularComponent	sarcomere	MYH1 MYH2 MYH3 MYH4 MYH8 SYNE1 STK11 DST HRC AHNAK2	4.20e-06	249	132	10	GO:0030017
GeneOntologyCellularComponent	myofibril	MYH1 MYH2 MYH3 MYH4 MYH8 SYNE1 STK11 DST HRC AHNAK2	9.43e-06	273	132	10	GO:0030016
GeneOntologyCellularComponent	actin cytoskeleton	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SPTB MYO18A MYRIP MYO5C DST TJP1	7.44e-05	576	132	13	GO:0015629
GeneOntologyCellularComponent	glutamatergic synapse	CACNA1B MYH10 GIT1 TSPOAP1 CANX SPTB STX4 SRGAP3 FARP1 SLC17A8 PRKCE SRGAP2B SLC9A6 ADGRL3	6.66e-04	817	132	14	GO:0098978
GeneOntologyCellularComponent	B-WICH complex	ERCC6 SF3B1	1.08e-03	8	132	2	GO:0110016
Domain	Myosin-like_IQ_dom	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	2.35e-15	19	129	9	IPR027401
Domain	-	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	2.35e-15	19	129	9	4.10.270.10
Domain	Myosin_N	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO5C	2.57e-14	15	129	8	PF02736
Domain	Myosin_N	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO5C	2.57e-14	15	129	8	IPR004009
Domain	Myosin_tail_1	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A	1.72e-13	18	129	8	PF01576
Domain	Myosin_tail	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A	1.72e-13	18	129	8	IPR002928
Domain	Myosin_head_motor_dom	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	3.71e-12	38	129	9	IPR001609
Domain	MYOSIN_MOTOR	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	3.71e-12	38	129	9	PS51456
Domain	Myosin_head	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	3.71e-12	38	129	9	PF00063
Domain	MYSc	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	3.71e-12	38	129	9	SM00242
Domain	IQ	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	1.40e-09	71	129	9	PF00612
Domain	IQ	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	4.63e-09	81	129	9	SM00015
Domain	IQ_motif_EF-hand-BS	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	1.19e-08	90	129	9	IPR000048
Domain	IQ	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	1.59e-08	93	129	9	PS50096
Domain	Myosin_S1_N	MYH10 MYH11 MYO5C	3.19e-06	5	129	3	IPR008989
Domain	FCH	PACSIN3 SRGAP3 SRGAP1 SRGAP2B	1.44e-05	22	129	4	PF00611
Domain	FCH	PACSIN3 SRGAP3 SRGAP1 SRGAP2B	1.44e-05	22	129	4	SM00055
Domain	FCH_dom	PACSIN3 SRGAP3 SRGAP1 SRGAP2B	1.74e-05	23	129	4	IPR001060
Domain	F_BAR	PACSIN3 SRGAP3 SRGAP1 SRGAP2B	2.46e-05	25	129	4	IPR031160
Domain	F_BAR	PACSIN3 SRGAP3 SRGAP1 SRGAP2B	2.46e-05	25	129	4	PS51741
Domain	ZO	TJP1 TJP3	1.41e-04	3	129	2	IPR005417
Domain	EF-hand-dom_pair	CACNA1B NUCB1 PPP2R3B ZZEF1 STAT5A EHD2 PLCD3 DST PLCD1	1.73e-04	287	129	9	IPR011992
Domain	EF_HAND_2	CACNA1B NUCB1 PPP2R3B ZZEF1 EHD2 PLCD3 DST PLCD1	2.05e-04	231	129	8	PS50222
Domain	PPR	DENND4A DENND4C	2.81e-04	4	129	2	PF01535
Domain	Mib_Herc2	MIB2 HECTD1	2.81e-04	4	129	2	IPR010606
Domain	MIB_HERC2	MIB2 HECTD1	2.81e-04	4	129	2	PS51416
Domain	SCD	STAG1 STAG3	2.81e-04	4	129	2	PS51425
Domain	MIB_HERC2	MIB2 HECTD1	2.81e-04	4	129	2	PF06701
Domain	SCD	STAG1 STAG3	2.81e-04	4	129	2	IPR020839
Domain	STAG	STAG1 STAG3	2.81e-04	4	129	2	PF08514
Domain	STAG	STAG1 STAG3	2.81e-04	4	129	2	IPR013721
Domain	-	NUCB1 PPP2R3B ZZEF1 STAT5A EHD2 PLCD3 DST PLCD1	4.65e-04	261	129	8	1.10.238.10
Domain	Spectrin	SYNE1 SPTB DST	5.15e-04	23	129	3	PF00435
Domain	ACTININ_2	SYNE1 SPTB DST	5.15e-04	23	129	3	PS00020
Domain	ACTININ_1	SYNE1 SPTB DST	5.15e-04	23	129	3	PS00019
Domain	Actinin_actin-bd_CS	SYNE1 SPTB DST	5.15e-04	23	129	3	IPR001589
Domain	-	IGF2R M6PR	6.97e-04	6	129	2	2.70.130.10
Domain	SH3	TSPOAP1 PACSIN3 DST TJP1 SRGAP3 SRGAP1 TJP3	7.62e-04	216	129	7	PS50002
Domain	P-loop_NTPase	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 ERCC6 MYO18A MYO5C EHD2 TJP1 MTIF2 NLRC5 TJP3	7.63e-04	848	129	15	IPR027417
Domain	HECT	UBR5 HECTD2 HECTD1	8.34e-04	27	129	3	PF00632
Domain	HECTc	UBR5 HECTD2 HECTD1	8.34e-04	27	129	3	SM00119
Domain	HECT_dom	UBR5 HECTD2 HECTD1	8.34e-04	27	129	3	IPR000569
Domain	HECT	UBR5 HECTD2 HECTD1	8.34e-04	27	129	3	PS50237
Domain	SH3_domain	TSPOAP1 PACSIN3 DST TJP1 SRGAP3 SRGAP1 TJP3	8.49e-04	220	129	7	IPR001452
Domain	APC_su10/DOC_dom	MYCBP2 ZZEF1	9.72e-04	7	129	2	IPR004939
Domain	DOC	MYCBP2 ZZEF1	9.72e-04	7	129	2	PS51284
Domain	ANAPC10	MYCBP2 ZZEF1	9.72e-04	7	129	2	PF03256
Domain	APC10	MYCBP2 ZZEF1	9.72e-04	7	129	2	SM01337
Domain	Spectrin_repeat	SYNE1 SPTB DST	1.03e-03	29	129	3	IPR002017
Domain	EF_hand_dom	CACNA1B NUCB1 PPP2R3B ZZEF1 EHD2 DST PLCD1	1.16e-03	232	129	7	IPR002048
Domain	Man6P_isomerase_rcpt-bd_dom	IGF2R M6PR	1.29e-03	8	129	2	IPR009011
Domain	PPR	DENND4A DENND4C	1.29e-03	8	129	2	PS51375
Domain	EF_Hand_1_Ca_BS	NUCB1 PPP2R3B EHD2 PLCD3 DST PLCD1	1.37e-03	175	129	6	IPR018247
Domain	SPEC	SYNE1 SPTB DST	1.38e-03	32	129	3	SM00150
Domain	Spectrin/alpha-actinin	SYNE1 SPTB DST	1.38e-03	32	129	3	IPR018159
Domain	ZU5	TJP1 UNC5D	1.65e-03	9	129	2	SM00218
Domain	ZU5	TJP1 UNC5D	2.05e-03	10	129	2	PS51145
Domain	EF_HAND_1	NUCB1 PPP2R3B EHD2 PLCD3 DST PLCD1	2.95e-03	204	129	6	PS00018
Domain	PDZ	MYO18A TJP1 AHNAK2 PDZD2 TJP3	2.97e-03	141	129	5	PF00595
Domain	ZU5	TJP1 UNC5D	2.99e-03	12	129	2	PF00791
Domain	ZU5_dom	TJP1 UNC5D	2.99e-03	12	129	2	IPR000906
Domain	PDZ	MYO18A TJP1 AHNAK2 PDZD2 TJP3	3.66e-03	148	129	5	SM00228
Domain	-	MYO18A TJP1 AHNAK2 PDZD2 TJP3	3.87e-03	150	129	5	2.30.42.10
Domain	SH3	TSPOAP1 PACSIN3 TJP1 SRGAP3 SRGAP1 TJP3	3.91e-03	216	129	6	SM00326
Domain	PDZ	MYO18A TJP1 AHNAK2 PDZD2 TJP3	3.99e-03	151	129	5	PS50106
Domain	PDZ	MYO18A TJP1 AHNAK2 PDZD2 TJP3	4.10e-03	152	129	5	IPR001478
Domain	EF-hand_like	PLCD3 PLCD1	4.69e-03	15	129	2	PF09279
Domain	PI-PLC-Y	PLCD3 PLCD1	4.69e-03	15	129	2	PF00387
Domain	PLCYc	PLCD3 PLCD1	4.69e-03	15	129	2	SM00149
Domain	PLipase_C_Pinositol-sp_Y	PLCD3 PLCD1	4.69e-03	15	129	2	IPR001711
Domain	PIPLC_Y_DOMAIN	PLCD3 PLCD1	4.69e-03	15	129	2	PS50008
Domain	PI-PLC_fam	PLCD3 PLCD1	4.69e-03	15	129	2	IPR001192
Domain	PLC_EF-hand-like	PLCD3 PLCD1	4.69e-03	15	129	2	IPR015359
Domain	DENN	DENND4A DENND4C	5.33e-03	16	129	2	SM00799
Domain	DENN	DENND4A DENND4C	5.33e-03	16	129	2	PF02141
Domain	dDENN	DENND4A DENND4C	5.33e-03	16	129	2	PF03455
Domain	UDENN	DENND4A DENND4C	5.33e-03	16	129	2	PS50946
Domain	DDENN	DENND4A DENND4C	5.33e-03	16	129	2	PS50947
Domain	dDENN	DENND4A DENND4C	5.33e-03	16	129	2	SM00801
Domain	dDENN_dom	DENND4A DENND4C	5.33e-03	16	129	2	IPR005112
Domain	uDENN_dom	DENND4A DENND4C	5.33e-03	16	129	2	IPR005113
Domain	DENN	DENND4A DENND4C	5.33e-03	16	129	2	PS50211
Domain	DENN_dom	DENND4A DENND4C	5.33e-03	16	129	2	IPR001194
Domain	ZF_ZZ_2	MIB2 ZZEF1	6.74e-03	18	129	2	PS50135
Domain	PI-PLC-X	PLCD3 PLCD1	6.74e-03	18	129	2	PF00388
Domain	ZF_ZZ_1	MIB2 ZZEF1	6.74e-03	18	129	2	PS01357
Domain	PLCXc	PLCD3 PLCD1	6.74e-03	18	129	2	SM00148
Domain	ZZ	MIB2 ZZEF1	6.74e-03	18	129	2	PF00569
Pathway	KEGG_TIGHT_JUNCTION	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 TJP1 PRKCE TJP3	5.47e-08	132	106	10	M11355
Pathway	KEGG_VIRAL_MYOCARDITIS	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	9.04e-07	70	106	7	M12294
Pubmed	Developmental pattern of mouse skeletal myosin heavy chain gene transcripts in vivo and in vitro.	MYH1 MYH2 MYH3 MYH4 MYH8	7.58e-13	5	133	5	3829126
Pubmed	Sequential accumulation of mRNAs encoding different myosin heavy chain isoforms during skeletal muscle development in vivo detected with a recombinant plasmid identified as coding for an adult fast myosin heavy chain from mouse skeletal muscle.	MYH1 MYH2 MYH3 MYH4 MYH8	7.58e-13	5	133	5	6196357
Pubmed	Distinct myogenic programs of embryonic and fetal mouse muscle cells: expression of the perinatal myosin heavy chain isoform in vitro.	MYH1 MYH2 MYH3 MYH4 MYH8	4.54e-12	6	133	5	1728586
Pubmed	Organization of human and mouse skeletal myosin heavy chain gene clusters is highly conserved.	MYH1 MYH2 MYH3 MYH4 MYH8	4.54e-12	6	133	5	10077619
Pubmed	Spatial and temporal changes in myosin heavy chain gene expression in skeletal muscle development.	MYH1 MYH2 MYH3 MYH4 MYH8	4.54e-12	6	133	5	10588881
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	USP34 CASP8AP2 NOL4 HIVEP1 MYCBP2 ATG2B ELP6 MSTO1 DENND4C DST UBR5 BUB1 ANKRD17 MGA GOLGB1 PCNT	7.08e-12	418	133	16	34709266
Pubmed	A fast Myosin super enhancer dictates muscle fiber phenotype through competitive interactions with Myosin genes.	MYH1 MYH2 MYH3 MYH4 MYH8	1.58e-11	7	133	5	35210422
Pubmed	Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts.	MYH1 MYH2 MYH3 MYH4 MYH8	1.58e-11	7	133	5	16819597
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	MYH10 TSPOAP1 IFT172 SYNE1 GON4L PJA2 UBR5 SRGAP3 ACIN1 FNIP1 ARRDC3 SLC9A6 ADGRL3 PCNT PDZD2	5.67e-11	407	133	15	12693553
Pubmed	N-Terminomics for the Identification of In Vitro Substrates and Cleavage Site Specificity of the SARS-CoV-2 Main Protease.	MYH10 SPTB NUMA1 ELP6 EHD2 RALY DST TJP1 ZNF638 ACIN1 CAVIN2 GOLGB1 AHNAK2 PCNT	1.27e-10	360	133	14	33111431
Pubmed	Evaluation of embryonic and perinatal myosin gene mutations and the etiology of congenital idiopathic clubfoot.	MYH1 MYH2 MYH3 MYH8	2.04e-10	4	133	4	20357587
Pubmed	Three linked myosin heavy chain genes clustered within 370 kb of each other show independent transcriptional and post-transcriptional regulation during differentiation of a mouse muscle cell line.	MYH1 MYH3 MYH4 MYH8	2.04e-10	4	133	4	1985022
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 MYH10 MYCBP2 CANX NUMA1 SRPK1 PPM1G IGF2R SF3B1 DST UBR5 TJP1 ZNF638 ACIN1 ANKRD17 HECTD1 PCNT	5.97e-10	653	133	17	22586326
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	DMXL2 TCAF1 MYH10 GIT1 MYCBP2 SYNE1 CANX NUMA1 IGF2R SF3B1 DST UBR5 TJP1 SRGAP3 FARP1 ANKRD17 PRKCE MGA GOLGB1 PCNT	8.28e-10	963	133	20	28671696
Pubmed	Contractile protein gene expression in primary myotubes of embryonic mouse hindlimb muscles.	MYH1 MYH2 MYH3 MYH4 MYH8	9.52e-10	13	133	5	8404542
Pubmed	The inhibition of differentiation caused by TGFbeta in fetal myoblasts is dependent upon selective expression of PKCtheta: a possible molecular basis for myoblast diversification during limb histogenesis.	MYH1 MYH2 MYH3 MYH8 PRKCE	9.52e-10	13	133	5	8948582
Pubmed	Myosin heavy chain isoforms of the murine masseter muscle during pre- and post-natal development.	MYH1 MYH2 MYH4 MYH8	1.02e-09	5	133	4	12919077
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	MYH1 MYH2 MYH3 MYH4 MYH8 DENND4A MYH10 MYH11 STAG1 SYNE1 NUCB1 NUMA1 MYO18A MYRIP RALY STK11 SF3B1 DST TJP1 ACIN1 CC2D2A CAVIN2 GOLGB1 PCNT	1.19e-09	1442	133	24	35575683
Pubmed	Defective excitation-contraction coupling is partially responsible for impaired contractility in hindlimb muscles of Stac3 knockout mice.	MYH1 MYH2 MYH3 MYH4 MYH8	1.48e-09	14	133	5	27184118
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	USP34 DMXL2 STAG1 GIT1 MYCBP2 IFT172 SYNE1 SPTB NUCB1 MYRIP NCAPH2 CACHD1 MSTO1 SF3B1 DST SLF2 TJP1 HECTD2 MTIF2 EXOC7 HECTD1 PCNT	3.85e-09	1285	133	22	35914814
Pubmed	A human MAP kinase interactome.	CASP8AP2 MYH10 MYH11 HIVEP1 SYNE1 MKNK2 MYO18A TTC1 SF3B1 DST ANKRD17 PRKCE MGA GOLGB1	6.05e-09	486	133	14	20936779
Pubmed	ANKK1 is found in myogenic precursors and muscle fibers subtypes with glycolytic metabolism.	MYH1 MYH2 MYH3 MYH4	7.09e-09	7	133	4	29758057
Pubmed	The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1.	USP34 MYCBP2 NCAPH2 ZZEF1 PJA2 RPIA DST ANKRD17 HECTD1 PCNT	1.01e-08	212	133	10	33853758
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	CACNA1B DMXL2 GIT1 MYCBP2 CANX MYO18A PACSIN3 KL DST SRGAP3 PRKCE ADGRL3	1.05e-08	347	133	12	17114649
Pubmed	Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains.	CASP8AP2 DMXL2 MYCBP2 SYNE1 CANX NUCB1 MYO18A SRPK1 TTC1 PPM1G RALY PJA2 NAA35 IGF2R SF3B1 UBR5 MTIF2 FARP1 MRPL46 ZNHIT2 M6PR GOLGB1 PCNT	1.09e-08	1487	133	23	33957083
Pubmed	Neuron-specific protein network mapping of autism risk genes identifies shared biological mechanisms and disease-relevant pathologies.	CACNA1B DMXL2 MYH10 GIT1 MYCBP2 TSPOAP1 CANX ATG2B MYO18A TACC2 MIB2 NACAD PPM1G RALY PJA2 SF3B1 TJP1 SRGAP3 FARP1 ADGRL3	1.41e-08	1139	133	20	36417873
Pubmed	Genes for skeletal muscle myosin heavy chains are clustered and are not located on the same mouse chromosome as a cardiac myosin heavy chain gene.	MYH1 MYH3 MYH4 MYH8	1.41e-08	8	133	4	3864153
Pubmed	A new role for the calcineurin/NFAT pathway in neonatal myosin heavy chain expression via the NFATc2/MyoD complex during mouse myogenesis.	MYH1 MYH2 MYH3 MYH4 MYH8	1.90e-08	22	133	5	24301466
Pubmed	Acceleration of somitic myogenesis in embryos of myogenin promoter-MRF4 transgenic mice.	MYH1 MYH2 MYH3 MYH8	4.22e-08	10	133	4	8950513
Pubmed	Transition of myosin heavy chain isoforms in human laryngeal abductors following denervation.	MYH1 MYH2 MYH4	5.47e-08	3	133	3	26059207
Pubmed	Simultaneous loss of skeletal muscle myosin heavy chain IIx and IIb causes severe skeletal muscle hypoplasia in postnatal mice.	MYH1 MYH4 MYH10	5.47e-08	3	133	3	36515178
Pubmed	Molecular determinants of force production in human skeletal muscle fibers: effects of myosin isoform expression and cross-sectional area.	MYH1 MYH2 MYH10	5.47e-08	3	133	3	25567808
Pubmed	Defining the human deubiquitinating enzyme interaction landscape.	MYH2 MYH4 TCAF1 MYH10 HIVEP1 DSC1 MYCBP2 PPM1G IWS1 RALY STK11 PJA2 IGF2R UBR5 TJP1 UCHL3 ANKRD17 HECTD1	5.93e-08	1005	133	18	19615732
Pubmed	Modulation of contractile protein gene expression in fetal murine crural muscles: emergence of muscle diversity.	MYH1 MYH2 MYH4 MYH8	6.61e-08	11	133	4	8136524
Pubmed	Calcineurin is necessary for the maintenance but not embryonic development of slow muscle fibers.	MYH1 MYH2 MYH3 MYH4	6.61e-08	11	133	4	16024798
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	MYCBP2 SYNE1 CANX NUMA1 PACSIN3 MYO5C RALY IGF2R STX4 SF3B1 DST UBR5 TJP1 ZNF638 ACIN1 MGA GOLGB1 PCNT	7.85e-08	1024	133	18	24711643
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	MYH4 MYH10 MYH11 NUMA1 MYO18A SRPK1 MYO5C ANKRD17 HECTD1	9.20e-08	202	133	9	33005030
Pubmed	Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1.	MYH10 GIT1 ATG2B PPM1G IGF2R SF3B1 TJP1 ANKRD17 MGA	1.56e-07	215	133	9	35973513
Pubmed	A protein interaction landscape of breast cancer.	AVEN MYH10 DSC1 MYO18A SRPK1 PPM1G RALY STK11 SLC7A2 IGF2R DST UBR5 ACIN1 CAVIN2	1.62e-07	634	133	14	34591612
Pubmed	Myosin heavy chain-embryonic regulates skeletal muscle differentiation during mammalian development.	MYH1 MYH2 MYH3 MYH4 MYH8	1.65e-07	33	133	5	32094117
Pubmed	The E3 ubiquitin ligase FBXL6 controls the quality of newly synthesized mitochondrial ribosomal proteins.	TCAF1 CANX GON4L ELP6 SRPK1 PPM1G PJA2 DST UBR5 ANKRD17 MRPL46 MGA HECTD1	2.00e-07	547	133	13	37267103
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DENND4A HIVEP1 GIT1 MYCBP2 DENND4C PJA2 DST SLF2 TJP1 SRGAP1 ANKRD17 FNIP1 PRKCE HECTD1 GOLGB1 AHNAK2	2.09e-07	861	133	16	36931259
Pubmed	Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.	MYH1 MYH2 MYH4	2.18e-07	4	133	3	11029314
Pubmed	Modulation of skeletal muscle fiber type by mitogen-activated protein kinase signaling.	MYH1 MYH2 MYH4	2.18e-07	4	133	3	18417546
Pubmed	Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity.	MYH1 MYH2 MYH4	2.18e-07	4	133	3	10388558
Pubmed	A human YAC transgene rescues craniofacial and neural tube development in PDGFRalpha knockout mice and uncovers a role for PDGFRalpha in prenatal lung growth.	MYH1 MYH2 MYH4	2.18e-07	4	133	3	11023856
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	DMXL2 DENND4A GON4L SRPK1 MIB2 ZZEF1 PLCD3 DST MTIF2 BUB1 ZNF638 ANKRD17 CLSPN EXOC7	2.19e-07	650	133	14	38777146
Pubmed	Systematic Determination of Human Cyclin Dependent Kinase (CDK)-9 Interactome Identifies Novel Functions in RNA Splicing Mediated by the DEAD Box (DDX)-5/17 RNA Helicases.	MYH10 NUMA1 MYO18A EHD2 RALY SF3B1 TJP1 ZNF638 ACIN1 AHNAK2	2.23e-07	295	133	10	26209609
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	USP34 CASP8AP2 DMXL2 MYCBP2 SYNE1 DST UBR5 SRGAP3 PCNT	2.30e-07	225	133	9	12168954
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	USP34 MYCBP2 ELP6 MIB2 ZZEF1 PLCD3 IGF2R STX4 DST NLRC5 UNKL C3orf18 GPC2 MRPL46 HECTD1 AHNAK2 PCNT TJP3	2.41e-07	1105	133	18	35748872
Pubmed	Six homeoproteins and a Iinc-RNA at the fast MYH locus lock fast myofiber terminal phenotype.	MYH1 MYH2 MYH3 MYH4	2.70e-07	15	133	4	24852826
Pubmed	Temporal regulation of the Mediator complex during muscle proliferation, differentiation, regeneration, aging, and disease.	MYH1 MYH2 MYH3 MYH4 MYH8	3.93e-07	39	133	5	38690566
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	USP34 CASP8AP2 HIVEP1 GIT1 CANX TACC2 PPM1G UBR5 SLF2 BUB1 CLSPN GOLGB1 PCNT	4.54e-07	588	133	13	38580884
Pubmed	Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H.	MYH2 MYH3 MYH4 MYH8	4.68e-07	17	133	4	16124007
Pubmed	Functional proteomics mapping of a human signaling pathway.	MYH10 HIVEP1 ERCC6 STAG1 MYCBP2 CANX ZZEF1 PLCD3 SF3B1 DST UBR5 MGA GOLGB1	4.80e-07	591	133	13	15231748
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	MYH3 DMXL2 MYH8 DENND4A HIVEP1 GIT1 MYCBP2 SYNE1 SPTB GON4L DST MGA	5.11e-07	497	133	12	23414517
Pubmed	Multigene family for sarcomeric myosin heavy chain in mouse and human DNA: localization on a single chromosome.	MYH1 MYH2 MYH3	5.44e-07	5	133	3	6879174
Pubmed	Detection of Gene and Protein Expression in Mouse Embryos and Tissue Sections.	MYH1 MYH2 MYH4	5.44e-07	5	133	3	30737693
Pubmed	Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase.	HIVEP1 CACHD1 DENND4C FBXO5 TJP1 FNIP1 CLSPN	6.56e-07	128	133	7	25332235
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	MYH8 MYH10 NCAPH2 MSTO1 IWS1 NAA35 MTRF1 C1orf115 FBXO5 UBR5 GLI3 ANKRD17 UNKL CLSPN MGA HECTD1 ALOX12 CAVIN2 PCNT	7.64e-07	1327	133	19	32694731
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	NOL4 DMXL2 MYH10 MYCBP2 SYNE1 CANX MYO18A IWS1 RALY SF3B1 DST TJP1 FARP1 ZNF638 ACIN1 GPC2 MRPL46	8.80e-07	1082	133	17	38697112
Pubmed	HOXA5 plays tissue-specific roles in the developing respiratory system.	MYH1 MYH2 MYH3 MYH4 MYH8	9.16e-07	46	133	5	28827394
Pubmed	Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.	MYH8 IFT172 SYNE1 DST	9.44e-07	20	133	4	21689717
Pubmed	A hypoplastic model of skeletal muscle development displaying reduced foetal myoblast cell numbers, increased oxidative myofibres and improved specific tension capacity.	MYH1 MYH2 MYH4	1.08e-06	6	133	3	20417199
Pubmed	A role for Insulin-like growth factor 2 in specification of the fast skeletal muscle fibre.	MYH1 MYH2 MYH4	1.08e-06	6	133	3	17559643
Pubmed	RSPO-LGR4 functions via IQGAP1 to potentiate Wnt signaling.	MYH10 MYH11 MYCBP2 CANX NUMA1 SF3B1 ZNF638 ACIN1	1.19e-06	202	133	8	24639526
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	CASP8AP2 DSC1 SYNE1 CANX MYO18A P4HA3 PPM1G RALY SF3B1 UBR5 ZNF638 MGA STAG3 GOLGB1	1.28e-06	754	133	14	35906200
Pubmed	∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis.	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 DSC1 CANX MYO18A PJA2 UBR5 EXOC7	1.32e-06	647	133	13	26618866
Pubmed	Scanning the human proteome for calmodulin-binding proteins.	CASP8AP2 STAG1 MYCBP2 SF3B1 DST SLF2	1.52e-06	92	133	6	15840729
Pubmed	ZZW-115-dependent inhibition of NUPR1 nuclear translocation sensitizes cancer cells to genotoxic agents.	MYH10 NUMA1 MYO18A PACSIN3 SRPK1 IWS1 RALY SF3B1 DST TJP1 FARP1 ACIN1 CAVIN2	1.64e-06	660	133	13	32780723
Pubmed	Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones.	TCAF1 MYH10 GIT1 CANX NUMA1 PACSIN3 SRPK1 TACC2 PPM1G IWS1 SF3B1 UBR5 TJP1 ZNF638 MRPL46 ZNHIT2 HECTD1 GOLGB1 AHNAK2	1.97e-06	1415	133	19	28515276
Pubmed	Analysis of Ku70 S155 Phospho-Specific BioID2 Interactome Identifies Ku Association with TRIP12 in Response to DNA Damage.	DSC1 CANX NUMA1 PPM1G RALY ZNF638 MGA	2.47e-06	156	133	7	37108203
Pubmed	Genesis of muscle fiber-type diversity during mouse embryogenesis relies on Six1 and Six4 gene expression.	MYH1 MYH2 MYH3 MYH4 MYH8	2.95e-06	58	133	5	21884692
Pubmed	Cell lineage- and expression-based inference of the roles of forkhead box transcription factor Foxc2 in craniofacial development.	MYH1 MYH2 MYH4	3.02e-06	8	133	3	33667029
Pubmed	A Tcf4-positive mesodermal population provides a prepattern for vertebrate limb muscle patterning.	MYH1 MYH2 MYH4	3.02e-06	8	133	3	14667415
Pubmed	Neuromuscular junction immaturity and muscle atrophy are hallmarks of the ColQ-deficient mouse, a model of congenital myasthenic syndrome with acetylcholinesterase deficiency.	MYH1 MYH2 MYH4	3.02e-06	8	133	3	26993635
Pubmed	Long noncoding RNA lncMREF promotes myogenic differentiation and muscle regeneration by interacting with the Smarca5/p300 complex.	MYH1 MYH3 MYH4	3.02e-06	8	133	3	36200826
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	MYH10 DSC1 ATG2B NUMA1 TACC2 TTC1 SF3B1 DST TJP1 ZNF638 ACIN1 ANKRD17 GOLGB1 AHNAK2 PCNT	3.11e-06	934	133	15	33916271
Pubmed	A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase.	CACHD1 DENND4C SF3B1 UBR5 GLI3 FNIP1 CLSPN HECTD1	3.33e-06	232	133	8	25515538
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	HIVEP1 SYNE1 SRPK1 NACAD SF3B1 DST GLI3 UNKL	3.43e-06	233	133	8	37704626
Pubmed	A protein interaction network for Ecm29 links the 26 S proteasome to molecular motors and endosomal components.	MYH10 SYNE1 DST ANKRD17 GOLGB1	3.50e-06	60	133	5	20682791
Pubmed	GASP-2 overexpressing mice exhibit a hypermuscular phenotype with contrasting molecular effects compared to GASP-1 transgenics.	MYH1 MYH2 MYH4	4.52e-06	9	133	3	31960486
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	TCAF1 MYH10 DSC1 CANX MYO18A PACSIN3 TTC1 PPM1G IWS1 RALY IGF2R SF3B1 TJP1 ACIN1 ANKRD17 M6PR GOLGB1 AHNAK2	4.93e-06	1367	133	18	32687490
Pubmed	Autophagy controls neonatal myogenesis by regulating the GH-IGF1 system through a NFE2L2- and DDIT3-mediated mechanism.	MYH1 MYH2 MYH4 STAT5A	5.94e-06	31	133	4	30081710
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	USP34 NOL4 ERCC6 IYD ZZEF1 RALY PJA2 NAA35 FBXO5 UBR5 MTIF2 GLI3 ANKRD17 CLSPN MGA UNC5D	6.04e-06	1116	133	16	31753913
Pubmed	The expression of myosin genes in developing skeletal muscle in the mouse embryo.	MYH3 MYH4 MYH8	6.43e-06	10	133	3	2211821
Pubmed	Cell polarity and spindle orientation in the distal epithelium of embryonic lung.	MYH10 NUMA1 PCNT	6.43e-06	10	133	3	21246661
Pubmed	During muscle atrophy, thick, but not thin, filament components are degraded by MuRF1-dependent ubiquitylation.	MYH1 MYH4 MYH8	6.43e-06	10	133	3	19506036
Pubmed	Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma.	MYH10 ERCC6 DSC1 CANX NUMA1 MYO18A PACSIN3 SRPK1 PPM1G RALY SF3B1 DST TJP1 SRGAP1 ZNF638 ACIN1 ANKRD17	6.53e-06	1257	133	17	36526897
Pubmed	HOXA5 Participates in Brown Adipose Tissue and Epaxial Skeletal Muscle Patterning and in Brown Adipocyte Differentiation.	MYH2 MYH3 MYH4 MYH8	6.76e-06	32	133	4	33732701
Pubmed	Kelch Domain of Gigaxonin Interacts with Intermediate Filament Proteins Affected in Giant Axonal Neuropathy.	SYNE1 SPTB MYO18A ZZEF1 DST ZNHIT2 PCNT	8.16e-06	187	133	7	26460568
Pubmed	Deletion of the protein kinase A/protein kinase G target SMTNL1 promotes an exercise-adapted phenotype in vascular smooth muscle.	MYH1 MYH2 MYH4	8.82e-06	11	133	3	18310078
Pubmed	Extracellular matrix protein composition dynamically changes during murine forelimb development.	MYH1 MYH2 MYH4	8.82e-06	11	133	3	38303699
Pubmed	The histone code reader Spin1 controls skeletal muscle development.	MYH1 MYH2 MYH4	8.82e-06	11	133	3	29168801
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 AVEN PPM1G IGF2R SF3B1 DST UBR5 TJP1 GLI3 ZNF638 CLSPN MGA GOLGB1	9.54e-06	777	133	13	35844135
Pubmed	ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells.	MYH10 CANX ATG2B MYO18A SRPK1 MYO5C TJP1 AHNAK2	9.56e-06	268	133	8	33024031
Pubmed	Dysregulation of nuclear receptor COUP-TFII impairs skeletal muscle development.	MYH2 MYH3 MYH8	1.17e-05	12	133	3	28600496
Pubmed	Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells.	MYH10 NUMA1 PPM1G RALY SF3B1 ZNF638 ACIN1 MGA	1.42e-05	283	133	8	30585729
Pubmed	Myosin heavy chains IIa and IId are functionally distinct in the mouse.	MYH1 MYH2	1.45e-05	2	133	2	9585413
Pubmed	Expression and function of phospholipase C in breast carcinoma.	PLCD3 PLCD1	1.45e-05	2	133	2	19344632
Interaction	HDAC1 interactions	CASP8AP2 MYH1 MYH2 MYH4 MYH8 MYH10 HIVEP1 ERCC6 STAG1 MYCBP2 ATG2B GON4L ELP6 DENND4C STAT5A DST UBR5 GLI3 BUB1 ZNF638 ANKRD17 MGA HECTD1 GOLGB1 PCNT	5.01e-08	1108	132	25	int:HDAC1
Interaction	PHF21A interactions	USP34 CASP8AP2 NOL4 HIVEP1 MYCBP2 ATG2B ELP6 DENND4C DST UBR5 BUB1 MGA GOLGB1 PCNT	5.89e-08	343	132	14	int:PHF21A
Interaction	AURKC interactions	MYH1 MYH4 MYH8 MYH11 SRPK1 TACC2	3.52e-07	43	132	6	int:AURKC
Interaction	TMEM260 interactions	MYH1 MYH3 MYH4 CANX	1.20e-06	13	132	4	int:TMEM260
Interaction	CCDC8 interactions	MYCBP2 CANX NUMA1 PACSIN3 IL20RA P4HA3 MYO5C RALY IGF2R STX4 SF3B1 DST UBR5 TJP1 HECTD1 GOLGB1 PCNT	1.39e-06	656	132	17	int:CCDC8
Interaction	RSPH6A interactions	MYH1 MYH2 MYH4 MYH8 TCAF1	2.67e-06	34	132	5	int:RSPH6A
Interaction	KDM1A interactions	USP34 CASP8AP2 NOL4 HIVEP1 MYCBP2 ATG2B ELP6 TTC1 MSTO1 DENND4C DST UBR5 SRGAP3 BUB1 ANKRD17 UNKL EXOC7 MGA GOLGB1 PCNT	3.24e-06	941	132	20	int:KDM1A
Interaction	ABTB2 interactions	MYH1 MYH2 MYH3 MYH4 MYH8 IFT172 ATG2B	4.55e-06	101	132	7	int:ABTB2
Interaction	RCOR1 interactions	USP34 CASP8AP2 NOL4 MYH10 HIVEP1 MYCBP2 ATG2B NUMA1 DENND4C DST UBR5 BUB1 ANKRD17 MGA	4.59e-06	494	132	14	int:RCOR1
Interaction	DISC1 interactions	TCAF1 TSPOAP1 SYNE1 P4HA3 PLCD3 IGF2R DST UBR5 SRGAP3 MRPL46 EXOC7 CCDC136 PCNT	4.99e-06	429	132	13	int:DISC1
Interaction	ECT2 interactions	MYH10 MYH11 MYCBP2 SPTB NUMA1 MYO18A PACSIN3 SRPK1 PPM1G MYO5C SF3B1 DST TJP1 FARP1 ACIN1 HECTD1 STAG3 AHNAK2 PDZD2	5.24e-06	887	132	19	int:ECT2
Interaction	ASAH2 interactions	MYH1 MYH3 MYH4	5.41e-06	6	132	3	int:ASAH2
Interaction	CHMP4B interactions	MYH10 MYH11 MYCBP2 CANX SPTB NUMA1 PACSIN3 IGF2R SF3B1 FBXO5 UBR5 TJP1 FARP1 STAG3 GOLGB1 AHNAK2 PDZD2	5.50e-06	727	132	17	int:CHMP4B
Interaction	SRGAP2 interactions	DENND4A CANX DENND4C SLC7A2 SRGAP3 SRGAP1 ZNF638 HECTD1 PCNT	6.11e-06	197	132	9	int:SRGAP2
Interaction	SIRT7 interactions	USP34 MYH10 MYCBP2 CANX NUMA1 SRPK1 PPM1G IGF2R SF3B1 DST UBR5 TJP1 ZNF638 ACIN1 ANKRD17 HECTD1 PCNT	7.46e-06	744	132	17	int:SIRT7
Interaction	LRRC31 interactions	MYH4 MYH10 MYH11 NUMA1 MYO18A SRPK1 MYO5C ANKRD17 HECTD1	8.44e-06	205	132	9	int:LRRC31
Interaction	CDK9 interactions	MYH10 SPTB NUMA1 MYO18A EHD2 RALY PJA2 SF3B1 ATRIP UBR5 TJP1 ZNF638 ACIN1 ARRDC3 CLSPN AHNAK2	1.08e-05	685	132	16	int:CDK9
Interaction	DYRK1A interactions	USP34 MYH11 MYCBP2 NUCB1 TBC1D2 SRPK1 NCAPH2 CACHD1 PPM1G SF3B1 ARRDC3 GOLGB1 AHNAK2 PCNT	1.61e-05	552	132	14	int:DYRK1A
Interaction	GOLGA1 interactions	ATG2B DENND4C IGF2R DST FNIP1 GOLGB1 AHNAK2 PCNT	2.80e-05	183	132	8	int:GOLGA1
Interaction	EGLN3 interactions	USP34 DMXL2 TCAF1 DENND4A MYCBP2 IFT172 CANX NUCB1 ATG2B NCAPH2 CACHD1 MSTO1 PPM1G PJA2 IGF2R UBR5 GLI3 ANKRD17 CLSPN EXOC7 MGA HECTD1	3.47e-05	1296	132	22	int:EGLN3
Interaction	RHOQ interactions	GIT1 MYO18A PACSIN3 CACHD1 EHD2 SLC7A2 IGF2R STX4 DST FARP1 EXOC7 GOLGB1	3.47e-05	442	132	12	int:RHOQ
Interaction	YWHAZ interactions	DMXL2 DENND4A MYH10 MYH11 HIVEP1 DSC1 GIT1 MYCBP2 MYO18A TACC2 DENND4C RALY SF3B1 DST TJP1 SRGAP3 SRGAP1 ZNF638 ANKRD17 PRKCE HECTD1 PCNT	4.52e-05	1319	132	22	int:YWHAZ
Interaction	RAB4A interactions	DMXL2 DENND4A SYNE1 ATG2B CACHD1 DENND4C SLC7A2 IGF2R STX4 DST GOLGB1 AHNAK2	4.79e-05	457	132	12	int:RAB4A
Interaction	AKAP17A interactions	MYH3 MYH4 DST UBR5 ANKRD17 HECTD1	4.79e-05	99	132	6	int:AKAP17A
Interaction	APC interactions	MYH10 MYH11 MYCBP2 SYNE1 STX4 DST UBR5 BUB1 ANKRD17 RP1 HECTD1	5.17e-05	389	132	11	int:APC
Interaction	CGN interactions	DENND4A MYH11 MYO18A DENND4C MYO5C TJP1 ZNF638	6.48e-05	152	132	7	int:CGN
Interaction	FBXW11 interactions	HIVEP1 CACHD1 DENND4C RALY STK11 SF3B1 FBXO5 UBR5 GLI3 FNIP1 CLSPN HECTD1	6.65e-05	473	132	12	int:FBXW11
Interaction	DHRS4L2 interactions	MYCBP2 ZZEF1 MTIF2	7.49e-05	13	132	3	int:DHRS4L2
Interaction	PRKAG2 interactions	MYH1 MYH2 MYH3 MYH4 MYH8	8.37e-05	68	132	5	int:PRKAG2
Interaction	OBSL1 interactions	CACNA1B SYNE1 CANX NUMA1 RALY KCNE4 SF3B1 DST ATRIP TJP1 ZNF638 ACIN1 FNIP1 MGA HECTD1 GOLGB1 PCNT	8.50e-05	902	132	17	int:OBSL1
Interaction	SLC39A3 interactions	MYH1 MYH2 MYH4 MYH8 IGF2R	9.61e-05	70	132	5	int:SLC39A3
Interaction	DTNBP1 interactions	SYNE1 P4HA3 MYO5C DST SRGAP3 EXOC7 PCNT	9.68e-05	162	132	7	int:DTNBP1
Interaction	FBXL6 interactions	TCAF1 CANX GON4L ELP6 SRPK1 PPM1G PJA2 DST UBR5 ANKRD17 MRPL46 MGA HECTD1	1.21e-04	583	132	13	int:FBXL6
Interaction	LYPD6B interactions	TCAF1 MYCBP2 MIB2 SEMA3B	1.21e-04	39	132	4	int:LYPD6B
Interaction	ACTN2 interactions	MYH1 MYH2 MYH3 MYH4 MYH8 NCAPH2 RALY	1.36e-04	171	132	7	int:ACTN2
Interaction	RICTOR interactions	MYH10 GIT1 MKNK2 ATG2B MYO18A NCAPH2 PPM1G IGF2R STX4 SF3B1 UBR5 TJP1 ANKRD17 MGA AHNAK2	1.36e-04	759	132	15	int:RICTOR
Interaction	HSPB8 interactions	USP34 MYH1 MYH2 MYH3 MYH4 MYH8 RPIA	1.41e-04	172	132	7	int:HSPB8
Interaction	LATS1 interactions	MYH1 MYH2 MYH3 MYH4 MYH8 RALY PJA2 SF3B1 TJP1 MGA PCNT	1.54e-04	440	132	11	int:LATS1
Interaction	EPHA1 interactions	USP34 ERCC6 STAG1 SYNE1 NUCB1 NCAPH2 DST EXOC7	1.62e-04	235	132	8	int:EPHA1
Interaction	FGFR2 interactions	CANX STAT5A IWS1 KL IGF2R DST M6PR SLC9A6	1.81e-04	239	132	8	int:FGFR2
Interaction	RIOK2 interactions	SRPK1 RALY STK11 FBXO5 ACIN1 HECTD1	1.82e-04	126	132	6	int:RIOK2
Interaction	KCNA3 interactions	CACNA1B CANX ATG2B NUMA1 MYO18A CACHD1 DENND4C PPM1G MYO5C KCNE4 IGF2R DST FBXO5 ANKRD17 RP1 GOLGB1	1.87e-04	871	132	16	int:KCNA3
Interaction	MED4 interactions	MYH11 GIT1 MYCBP2 ATG2B DENND4C PPM1G DST UBR5 ZNF638 HECTD1 PCNT	1.87e-04	450	132	11	int:MED4
Interaction	STK3 interactions	MYH1 MYH2 MYH3 MYH8 MYCBP2 FREM1 DST	1.93e-04	181	132	7	int:STK3
Interaction	TNIK interactions	GIT1 MYCBP2 SYNE1 IL20RA PLCD3 DST TJP1 SRGAP3 ARRDC3 MGA	2.09e-04	381	132	10	int:TNIK
Interaction	PRC1 interactions	ANKRD35 MYH10 SYNE1 SPTB NUMA1 MYO18A TACC2 ZZEF1 RALY SF3B1 TJP1 ZNF638 ACIN1 HECTD1 STAG3 GOLGB1 PDZD2	2.11e-04	973	132	17	int:PRC1
Interaction	RAD18 interactions	MYH10 SRPK1 IWS1 PLCD3 SLF2 TJP1 SRGAP3 SRGAP1 ZNF638 ACIN1 ARRDC3	2.13e-04	457	132	11	int:RAD18
Interaction	TOP3B interactions	USP34 MYH10 MYCBP2 SPTB ELP6 MIB2 ZZEF1 PLCD3 IGF2R STX4 DST NLRC5 ACIN1 ANKRD17 UNKL C3orf18 GPC2 MRPL46 HECTD1 AHNAK2 PCNT TJP3	2.18e-04	1470	132	22	int:TOP3B
Interaction	PDGFRA interactions	CANX PACSIN3 SRPK1 STAT5A STK11 DST FARP1 SEMA3B GOLGB1 AHNAK2	2.28e-04	385	132	10	int:PDGFRA
Interaction	NUP43 interactions	USP34 CASP8AP2 HIVEP1 DSC1 GON4L IWS1 DST UBR5 SLF2 ACIN1 MGA AHNAK2 PDZD2	2.38e-04	625	132	13	int:NUP43
Interaction	AHCYL1 interactions	USP34 MYH10 CANX SRPK1 TTC1 PPM1G PLCD3 UCHL3 HECTD1 PCNT	2.42e-04	388	132	10	int:AHCYL1
Interaction	GSK3A interactions	DENND4A MKNK2 ATG2B SRPK1 DENND4C DST UBR5 GLI3 ACIN1 FNIP1 HECTD1	2.43e-04	464	132	11	int:GSK3A
Interaction	MTNR1B interactions	USP34 DMXL2 CANX PPM1G DST HECTD1	2.65e-04	135	132	6	int:MTNR1B
Interaction	YWHAH interactions	DENND4A MYH11 HIVEP1 GIT1 MYCBP2 DENND4C PJA2 DST SLF2 TJP1 SRGAP1 ZNF638 CC2D2A ANKRD17 FNIP1 HECTD1 AHNAK2 PCNT	3.09e-04	1102	132	18	int:YWHAH
Interaction	LGR4 interactions	MYH10 MYH11 MYCBP2 CANX NUMA1 SF3B1 ZNF638 ACIN1	3.37e-04	262	132	8	int:LGR4
Interaction	DIRAS3 interactions	CACHD1 PPM1G SLC7A2 IGF2R DST MTIF2 FARP1 HECTD1	3.37e-04	262	132	8	int:DIRAS3
Interaction	DEF8 interactions	DMXL2 ATG2B MSTO1 ZNHIT2	3.46e-04	51	132	4	int:DEF8
Interaction	EXOC1 interactions	GIT1 DST C3orf18 EXOC7 HECTD1 PCNT	3.61e-04	143	132	6	int:EXOC1
Interaction	HDAC4 interactions	CACNA1B DENND4A STAG1 IFT172 PACSIN3 DENND4C PPM1G IWS1 DYDC1 NAA35 MTIF2 ZNF638 CCDC136 CAVIN2	3.78e-04	744	132	14	int:HDAC4
Interaction	ARL4D interactions	USP34 PPM1G SF3B1 ZNF638 CLSPN MGA	4.04e-04	146	132	6	int:ARL4D
Interaction	KIF23 interactions	MYH10 MYH11 DSC1 PACSIN3 SRPK1 MYO5C RALY STK11 SF3B1 FBXO5 UBR5 TJP1 FARP1 ACIN1 HECTD1 STAG3 AHNAK2	4.12e-04	1031	132	17	int:KIF23
Cytoband	17p13.1	MYH1 MYH2 MYH3 MYH4 MYH8 ALOX12	1.33e-06	118	133	6	17p13.1
Cytoband	Ensembl 112 genes in cytogenetic band chr17p13	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 ZZEF1 ALOX12	8.31e-06	346	133	8	chr17p13
GeneFamily	Myosin heavy chains	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	4.03e-13	15	91	7	1098
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	PACSIN3 SRGAP3 SRGAP1 SRGAP2B	4.94e-06	23	91	4	1288
GeneFamily	EF-hand domain containing	CACNA1B NUCB1 PPP2R3B ZZEF1 EHD2 DST PLCD1	1.19e-04	219	91	7	863
GeneFamily	Guanylate cyclase receptors\|DENN/MADD domain containing	DENND4A DENND4C FNIP1	2.62e-04	25	91	3	504
GeneFamily	CD molecules\|MRH domain containing	IGF2R M6PR	3.71e-04	6	91	2	1233
GeneFamily	Cohesin complex	STAG1 STAG3	6.88e-04	8	91	2	1060
GeneFamily	PDZ domain containing	MYO18A TJP1 AHNAK2 PDZD2 TJP3	1.02e-03	152	91	5	1220
GeneFamily	Zinc fingers ZZ-type\|Lysine acetyltransferases	MIB2 ZZEF1	3.64e-03	18	91	2	91
GeneFamily	Phospholipases\|C2 domain containing phospholipases	PLCD3 PLCD1	4.05e-03	19	91	2	832
Coexpression	BROWNE_HCMV_INFECTION_14HR_DN	ERCC6 SYNE1 SPTB NUMA1 DST TJP1 MTIF2 PRKCE PLCD1 AHNAK2	2.40e-06	290	133	10	M13251
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 MYH8	2.88e-06	20	133	4	M1123
Coexpression	HUMMERICH_BENIGN_SKIN_TUMOR_DN	MYH1 MYH2 MYH4 MYH8	3.55e-06	21	133	4	MM1102
Coexpression	GSE41978_ID2_KO_AND_BIM_KO_VS_BIM_KO_KLRG1_LOW_EFFECTOR_CD8_TCELL_DN	USP34 MYH1 MYH10 SYNE1 TACC2 STAT5A MYO5C SLC9A6	8.35e-06	199	133	8	M9567
Coexpression	GSE38696_LIGHT_ZONE_VS_DARK_ZONE_BCELL_UP	STAG1 MYCBP2 SYNE1 DENND4C SF3B1 UBR5 MTIF2	4.43e-05	184	133	7	M9005
Coexpression	GSE27291_0H_VS_7D_STIM_GAMMADELTA_TCELL_UP	DENND4A ATG2B GON4L ELP6 ZZEF1 GLI3 BUB1	5.08e-05	188	133	7	M8452
Coexpression	HALLMARK_MITOTIC_SPINDLE	MYH10 NUMA1 DST FBXO5 FARP1 BUB1 PCNT	7.26e-05	199	133	7	M5893
Coexpression	GSE19923_E2A_KO_VS_HEB_AND_E2A_KO_DP_THYMOCYTE_UP	MYH3 MYH8 RPIA ANKRD17 PRKCE M6PR PCNT	7.26e-05	199	133	7	M7274
Coexpression	GSE5589_LPS_AND_IL10_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_DN	USP34 DMXL2 GIT1 TBC1D2 MYO18A DENND4C TJP3	7.49e-05	200	133	7	M6626
Coexpression	HALLMARK_MYOGENESIS	MYH1 MYH2 MYH3 MYH4 MYH8 MYH11 HRC	7.49e-05	200	133	7	M5909
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-4\|TCGA-Prostate / Sample_Type by Project: Shred V9	ANKRD35 TBC1D2 CACHD1 NACAD STAT5A EHD2 PLCD3 DST GLI3	7.68e-09	195	133	9	5562665dd3beb70e2358aa32611a337bef5731c1
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	TBC1D2 MYO5C DST TJP1 FARP1 SEMA3B RP1 PDZD2	5.53e-08	174	133	8	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	TACC2 MYO5C DST TJP1 FARP1 RP1 PDZD2	8.10e-07	170	133	7	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 RSPH4A TSPOAP1 COL6A5 TTC34 FREM1 TJP3	1.38e-06	184	133	7	264e14aa1859cfc0ed5fb40e97ea189aed9ef4a5
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 RSPH4A TSPOAP1 COL6A5 TTC34 FREM1 TJP3	1.38e-06	184	133	7	d7eccbd21c480d907fdc8eff2bf5ae22ae452221
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D122\|Adult / Lineage, Cell type, age group and donor	TACC2 DST TJP1 FARP1 SEMA3B RP1 PDZD2	1.38e-06	184	133	7	561592edc3083fad41b91811151b442207c65dd9
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Epithelial-neuroepithelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH1 RSPH4A TSPOAP1 COL6A5 TTC34 FREM1 TJP3	1.38e-06	184	133	7	22010cfe0428ebfa40952cc1a1a12ad3d25b35c9
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MYO5C DST TJP1 FARP1 SEMA3B RP1 PDZD2	1.43e-06	185	133	7	1c222f7285d6e3dae0354dc7e853ddc0ea55e63e
ToppCell	PND10\|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYH10 MYH11 MYCBP2 DST ADGRL3 CAVIN2 GOLGB1	1.70e-06	190	133	7	d67e2814047c8df2ae4b7bc8be9539f5df6ecef2
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MYRIP EHD2 DST CCM2L TJP1 ALOX12 CAVIN2	1.76e-06	191	133	7	3307dbccadb09c62b0e1c0235ec89bb294d748c3
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH10 FREM1 DST SLF2 HECTD2 GLI3 SRGAP1	1.96e-06	194	133	7	35f132cc38ac133be01834ed0946188aa0757eb4
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	SLC7A2 DST TJP1 SRGAP3 HECTD1 GOLGB1 AHNAK2	2.39e-06	200	133	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH10 MYH11 SYNE1 TACC2 KCNE4 DST HECTD2	2.39e-06	200	133	7	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	TCAF1 MYH10 MYH11 SYNE1 TACC2 DST HECTD2	2.39e-06	200	133	7	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	SLC7A2 DST TJP1 SRGAP3 HECTD1 GOLGB1 AHNAK2	2.39e-06	200	133	7	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH1 MYH2 SPTB SLC7A2 STAG3 PCNT	4.75e-06	144	133	6	f92e03dd784e31a9e5dbd4f4c3a6517ea19210cf
ToppCell	COVID-19-Heart-CM_5_(RYR2-)\|Heart / Disease (COVID-19 only), tissue and cell type	MYH1 MYH2 SPTB SLC7A2 STAG3 PCNT	7.25e-06	155	133	6	d7e26696fd9c0a759524f331243db43059b33ed9
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH1 MYH2 MYH4 MYH8 FARP1 UNC5D	1.00e-05	164	133	6	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	E18.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-PMP-PMP_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	AVEN NOL4 TTC1 FARP1 GLI3 ADGRL3	1.19e-05	169	133	6	7cb1b87be66a22fe5731bb1b55bc515920fe3e8b
ToppCell	E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_vein\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	MYRIP CDH23 EHD2 DST CAVIN2 PDZD2	1.27e-05	171	133	6	3112d15f2a28cf4a71992db4971d960716dc1264
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH11 SPTB PACSIN3 EHD2 SLC7A2 HRC	1.50e-05	176	133	6	90f36f10c6ed440a0ca549f23219398853f1fbc3
ToppCell	AT1_cells-Donor_04\|World / lung cells shred on cell class, cell subclass, sample id	MYO5C EHD2 DST SEMA3B CAVIN2 AHNAK2	1.54e-05	177	133	6	3128b8d04687acee1ac4190b2569d6328b98eaf3
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma\|TCGA-Brain / Sample_Type by Project: Shred V9	TSPOAP1 SYNE1 NUMA1 MYO18A DST GOLGB1	1.54e-05	177	133	6	e8ab340b20cd41554c3841fe980e078e878af35f
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-Ependyma\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSPH4A MYRIP COL6A5 KL SEMA3B TJP3	1.70e-05	180	133	6	729f0d7af573c7796d8e28e6eec3af2fc0bd33a2
ToppCell	facs-Brain_Non-Myeloid-Striatum_-18m-Mesenchymal-ependymal_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RSPH4A MYRIP COL6A5 KL SEMA3B TJP3	1.70e-05	180	133	6	9ef79a7c60227e352ac166c7274adb31f585f5ca
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	GIT1 EHD2 TJP1 PRKCE ADGRL3 CAVIN2	1.70e-05	180	133	6	544fb373a3346186ec60afe2cfcf141bb04a1eed
ToppCell	PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_prolif\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	DMXL2 MSTO1 SLC7A2 RPIA BUB1 CLSPN	1.81e-05	182	133	6	57f8b8d7b132f3ad6f2b1e79c3812fe938657d2c
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)-\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EHD2 PLCD3 DST SEMA3B PLCD1 CAVIN2	1.92e-05	184	133	6	c7073d1b2c4fdb154d87678b92a0629c02116972
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5C DST TJP1 FARP1 SEMA3B PDZD2	1.92e-05	184	133	6	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	343B-Epithelial_cells-Epithelial-I_(AT1)\|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells)	EHD2 PLCD3 DST SEMA3B PLCD1 CAVIN2	1.92e-05	184	133	6	1ed558a88215b248431c524ea16f13d9022ae98c
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MYO5C DST TJP1 FARP1 SEMA3B PDZD2	1.92e-05	184	133	6	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	CACNA1B MYH1 MYH2 MYH3 MYH4 UNC5D	2.04e-05	186	133	6	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	DENND4A SYNE1 FARP1 GLI3 RP1 PDZD2	2.04e-05	186	133	6	f0c8de4f6ae9047b9108a47a2af8c5f42bc103b0
ToppCell	5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Pericyte\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SPTB EHD2 SLC7A2 HRC UNC5D ADGRL3	2.04e-05	186	133	6	0c477016c1b539b3086a8066c3c6443f08c222a3
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	MYO5C DST TJP1 FARP1 SEMA3B PDZD2	2.11e-05	187	133	6	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	droplet-Fat-SCAT-30m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 SYNE1 EHD2 C1orf115 TJP1 CAVIN2	2.17e-05	188	133	6	e901a9bdf00b8e91806f445af66647373bf62661
ToppCell	droplet-Fat-SCAT-30m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 SYNE1 EHD2 C1orf115 TJP1 CAVIN2	2.17e-05	188	133	6	5cf060bb8adaefa9964187195d67993c1248ef47
ToppCell	droplet-Fat-SCAT-30m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 SYNE1 EHD2 C1orf115 TJP1 CAVIN2	2.17e-05	188	133	6	449f9602df3c83b2110eb479a00d428d1b55b423
ToppCell	ASK454-Endothelial-Lymphatic\|Endothelial / Donor, Lineage and Cell class of Lung cells from Dropseq	MYH10 ZZEF1 MSTO1 NLRC5 ZNHIT2 M6PR	2.24e-05	189	133	6	316c857dec9383823e09f966bca62d52d933b141
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MYH10 FREM1 DST SRGAP3 HECTD2 GLI3	2.24e-05	189	133	6	203c80030df08ae112f9ae4043709f455d87ce89
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	STAG1 SYNE1 FREM1 FARP1 ANKRD17 RP1	2.24e-05	189	133	6	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D231\|Adult / Lineage, Cell type, age group and donor	MYO5C DST TJP1 FARP1 SEMA3B PDZD2	2.24e-05	189	133	6	5a04cb25f8f0447b2cecdb6c3695029281aca26d
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	DST TJP1 FARP1 SEMA3B RP1 PDZD2	2.30e-05	190	133	6	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	(4)_Endothelial_cells-(40)_EC-arterial\|(4)_Endothelial_cells / Cell class and subclass of bone marrow stroma cells in homeostatis	SYNE1 MYRIP TACC2 EHD2 CAVIN2 AHNAK2	2.30e-05	190	133	6	ff774faf3f12759d11e50ed7d189288bb79e22e1
ToppCell	Myeloid-Myeloid-B_(Activated_Macrophage)\|Myeloid / shred on cell class and cell subclass (v4)	DMXL2 CANX SLC7A2 DST M6PR AHNAK2	2.37e-05	191	133	6	7bf125249af1e8bb138ed4d999fdd74b03ab2447
ToppCell	Children_(3_yrs)-Epithelial\|Children_(3_yrs) / Lineage, Cell type, age group and donor	TACC2 CACHD1 MYO5C FARP1 RP1 PDZD2	2.37e-05	191	133	6	e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCell	droplet-Pancreas-Endocrine-18m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TACC2 DENND4C SLC7A2 DST GADD45G GOLGB1	2.44e-05	192	133	6	1304e69c92cef3bd8c82e3c035a7562f5440139a
ToppCell	droplet-Fat-Mat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 MYRIP C1orf115 DST TJP1 CAVIN2	2.52e-05	193	133	6	54024a373e42e1c0bcc327dc084564b83b63a9d4
ToppCell	droplet-Fat-Mat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 MYRIP C1orf115 DST TJP1 CAVIN2	2.52e-05	193	133	6	81d908594d2983ba7e7c1ec25afdde4315d9690e
ToppCell	droplet-Bladder-nan-3m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 MYRIP SLC7A2 C1orf115 KCNE4 CAVIN2	2.52e-05	193	133	6	8be24713f8ba2545b7647d1994e9e993623ddaa3
ToppCell	droplet-Bladder-nan-3m-Endothelial-endothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 MYRIP SLC7A2 C1orf115 KCNE4 CAVIN2	2.52e-05	193	133	6	19dfc4a2c91fcea4f5991e7c44df46faeecb06b8
ToppCell	droplet-Bladder-nan-3m-Endothelial\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYH11 MYRIP SLC7A2 C1orf115 KCNE4 CAVIN2	2.52e-05	193	133	6	351e0acd411a9eb0dbc0e358d0d1e3759753fa40
ToppCell	PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung	FREM1 DST SRGAP3 HECTD2 FARP1 GLI3	2.59e-05	194	133	6	b1bb0f846d2865efdd9bc8842b16b9d069785882
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c05-ZNF683\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANKRD35 TSPOAP1 SYNE1 IGF2R CLSPN PCNT	2.59e-05	194	133	6	24837a27b0041fe8c348225fa8b09b127d743603
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MYH10 SYNE1 COL6A5 FREM1 SLC7A2 SRGAP1	2.59e-05	194	133	6	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MYH1 MYH3 MYH8 P4HA3 KCNE4 HRC	2.59e-05	194	133	6	55b97095a7a17a312c616703d291738a0f806339
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBC1D2 MYO5C DST FARP1 SEMA3B RP1	2.67e-05	195	133	6	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)\|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung	FREM1 DST SRGAP3 HECTD2 FARP1 GLI3	2.67e-05	195	133	6	0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 SLC7A2 DST FNIP1 MGA GOLGB1	2.67e-05	195	133	6	3e519cffa6144a62b06124642a14c9ff39b76554
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYCBP2 SLC7A2 DST FNIP1 MGA GOLGB1	2.67e-05	195	133	6	7796ea9247f4c63762f0de8490fed08b9717fa23
ToppCell	Mid-temporal_gyrus_(MTG)-Neuronal\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CACNA1B MYH10 SYNE1 MYRIP PRKCE UNC5D	2.74e-05	196	133	6	676c56b44ac29f7baecb62f49bb8597cc74c0a88
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 EHD2 SLC7A2 KCNE4 HRC ADGRL3	2.74e-05	196	133	6	5146976881d79642ebe5dcbcf89e0252713a9ef2
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 EHD2 SLC7A2 KCNE4 HRC ADGRL3	2.74e-05	196	133	6	ebac1d6af7a5732707d82d01285c086b19d8ae62
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 SYNE1 COL6A5 FREM1 DST SRGAP1	2.82e-05	197	133	6	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 EHD2 SLC7A2 KCNE4 HRC ADGRL3	2.82e-05	197	133	6	d14e1f2ba94240c61eac435db43508a224d606a8
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	TBC1D2 DST TJP1 FARP1 SEMA3B RP1	2.82e-05	197	133	6	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	kidney_cells-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 EHD2 SLC7A2 KCNE4 HRC ADGRL3	2.82e-05	197	133	6	8b3bf5b45e49bf1c60e4d2703b470bb890385f67
ToppCell	BL-critical-LOC-Epithelial\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	RSPH4A TACC2 MYO5C TJP1 AHNAK2 TJP3	2.90e-05	198	133	6	6218a25b94d5fa2c69880539adf9c63bfe52dcd3
ToppCell	distal-3-mesenchymal-Vascular_Smooth_Muscle\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MYH10 MYH11 EHD2 KCNE4 HRC ADGRL3	2.90e-05	198	133	6	37ce7b485ffb207e75afd1b576b486c6d59fc136
ToppCell	COVID-19-lung-Fibroblast\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MYH10 CDH23 COL6A5 DST GLI3 SRGAP1	2.90e-05	198	133	6	3ec01a55ade5e1627258cc3cfebb2c3207a4cb43
ToppCell	kidney_cells-Hypertensive_with+without-CKD-Mesenchymal\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MYH11 EHD2 SLC7A2 KCNE4 HRC ADGRL3	2.90e-05	198	133	6	54c8aa47040bc4977eed382514fc4ceae03f54f8
ToppCell	COVID-19-Epithelial-AT2,_AT1_cells\|COVID-19 / Condition, Lineage and Cell class	PACSIN3 TACC2 EHD2 TJP1 SEMA3B CAVIN2	2.90e-05	198	133	6	7e6f089e71e70190ff8486341ab06719d7741467
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYH2 MYH10 COL6A5 FARP1 UNC5D ADGRL3	2.90e-05	198	133	6	7582ee9ec8a87ecb094201f1f9191b412f9d2875
ToppCell	Mild-Epithelial-Epithelial-\|Mild / Condition, Lineage, Cell class and cell subclass	RSPH4A IL20RA TACC2 SLC7A2 RP1 TJP3	2.99e-05	199	133	6	81115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH10 MYCBP2 SYNE1 COL6A5 FREM1 DST	2.99e-05	199	133	6	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	Mild-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	RSPH4A IL20RA TACC2 SLC7A2 RP1 TJP3	2.99e-05	199	133	6	ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH10 SYNE1 COL6A5 FREM1 DST SRGAP1	2.99e-05	199	133	6	30d3e8c0681ec11f86dd38c5f48d21187a1b4f90
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH10 SYNE1 COL6A5 FREM1 DST SRGAP1	2.99e-05	199	133	6	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Parenchymal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYH10 MYH11 SPTB KCNE4 HRC ADGRL3	2.99e-05	199	133	6	7c272a1aa7f3e931ad5d20809719d85b3bce4cb0
ToppCell	Mild-Epithelial-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	RSPH4A IL20RA TACC2 SLC7A2 RP1 TJP3	2.99e-05	199	133	6	91308b255783ad4029e5575028c18d7550832c51
ToppCell	LPS_IL1RA-Endothelial-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GIT1 EHD2 DST TJP1 ADGRL3 CAVIN2	3.07e-05	200	133	6	72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 SYNE1 COL6A5 FREM1 DST SRGAP1	3.07e-05	200	133	6	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Gen_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	USP34 DST UBR5 TJP1 ADGRL3 PCNT	3.07e-05	200	133	6	dccec522ab0d7fff62ad6273b02aa9022dbbb8eb
ToppCell	Bronchial-10x5prime-Stromal-Pericyte-Muscle_pericyte_pulmonary\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MYH11 SPTB EHD2 HRC UNC5D PDZD2	3.07e-05	200	133	6	12326cc6f0af24bacba9493dc79e7c7347db2f41
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 SYNE1 COL6A5 FREM1 DST SRGAP1	3.07e-05	200	133	6	b79628fd1386aa9a3b0e9fa81def0bc100c3c073
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 SYNE1 COL6A5 FREM1 DST SRGAP1	3.07e-05	200	133	6	50ca6550998e461ef26dd670351060bd940765a8
ToppCell	LPS_IL1RA-Endothelial\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GIT1 EHD2 DST TJP1 ADGRL3 CAVIN2	3.07e-05	200	133	6	5c092b2ecc081b5d04476c56333c338cd89ab984
ToppCell	Tracheal-NucSeq-Epithelial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYRIP TACC2 MYO5C SRGAP3 FARP1 SRGAP1	3.07e-05	200	133	6	d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCell	Neuronal\|World / cells hierarchy compared to all cells using T-Statistic	CACNA1B MYCBP2 SYNE1 MYRIP PRKCE UNC5D	3.07e-05	200	133	6	48d801219bc771d6c7e151dc88ca4c179988de85
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH10 MYH11 SYNE1 TACC2 KCNE4 HECTD2	3.07e-05	200	133	6	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Alv_Cap\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	GIT1 EHD2 KL TJP1 PRKCE CAVIN2	3.07e-05	200	133	6	66f7e8ee63c828f17468e79a4b816346b33e8980
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYH10 MYH11 SYNE1 TACC2 DST HECTD2	3.07e-05	200	133	6	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 MYH11 SYNE1 TACC2 DST HECTD2	3.07e-05	200	133	6	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	GIT1 EHD2 KL TJP1 PRKCE CAVIN2	3.07e-05	200	133	6	b7533c571eeea0cb3678e1a57d3dc036fa8d0f49
ToppCell	LPS_IL1RA-Endothelial-Endothelial-Alv_Cap\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	GIT1 EHD2 KL TJP1 PRKCE CAVIN2	3.07e-05	200	133	6	7034f57e282982c19c13ee8ab78eabaffa069e30
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	MYH10 MYH11 SYNE1 TACC2 KCNE4 HECTD2	3.07e-05	200	133	6	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Mesenchymal-Mesoderm\|3m / Sample Type, Dataset, Time_group, and Cell type.	MYH2 MYH3 MYH8 SPTB IL20RA HRC	3.07e-05	200	133	6	538ae964db58c4acafe93f735b3e03fc08fdaac6
ToppCell	LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_only / Treatment groups by lineage, cell group, cell type	MYH10 MYCBP2 COL6A5 FREM1 DST SRGAP1	3.07e-05	200	133	6	a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2
ToppCell	Control_saline-Endothelial-Endothelial-Alv_Cap\|Control_saline / Treatment groups by lineage, cell group, cell type	GIT1 EHD2 KL TJP1 PRKCE CAVIN2	3.07e-05	200	133	6	abf4ba5fcb54cdeada0da1a8b956a30aa47679e4
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	MYH11 SYNE1 TACC2 KCNE4 DST HECTD2	3.07e-05	200	133	6	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
Drug	formycin triphosphate	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	1.49e-11	51	133	9	CID000122274
Drug	purealin	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	5.04e-11	58	133	9	CID006419303
Drug	nocodazole	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SPTB NUMA1 MYO18A MYRIP MYO5C BUB1 EXOC7 M6PR GOLGB1 PCNT	2.87e-09	477	133	17	CID000004122
Drug	fast white	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	4.50e-09	42	133	7	CID000024008
Drug	S-(-)-Etomoxir	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	7.32e-09	100	133	9	CID000060765
Drug	blebbistatin	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	2.71e-08	116	133	9	CID003476986
Drug	B0683	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	2.92e-08	117	133	9	CID006398969
Drug	eye gene	GPLD1 MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A PPM1G MYO5C PRKCE PLCD1 ALOX12	3.62e-08	369	133	14	CID000004782
Drug	oxovanadium	MYH1 AVEN MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 CANX	3.65e-08	120	133	9	CID000024411
Drug	clenbuterol	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C	1.56e-07	142	133	9	CID000002783
Drug	candesartan cilexetil	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A DST	1.87e-07	145	133	9	CID000002540
Drug	NSC107658	GPLD1 MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C KL PRKCE	2.52e-07	306	133	12	CID000002919
Drug	trifluoperazine	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A PPM1G MYO5C PRKCE ALOX12	4.64e-07	324	133	12	CID000005566
Drug	SM-2	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	7.85e-07	87	133	7	CID000486033
Drug	N-ethylmaleimide	GPLD1 MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A MYO5C SLC7A2 STX4 MTIF2 GOLGB1	1.84e-06	511	133	14	CID000004362
Drug	isoproterenol	GPLD1 CACNA1B MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 IYD MYO18A MYRIP MYO5C KL STX4 PRKCE	1.91e-06	669	133	16	CID000003779
Drug	NSC339663	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SYNE1 MYO18A MYO5C	2.20e-06	250	133	10	CID000003892
Drug	carvedilol	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A	4.87e-06	161	133	8	CID000002585
Drug	wartmannin	GPLD1 MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A STAT5A MYO5C IGF2R STX4 PRKCE EXOC7 M6PR GOLGB1	5.23e-06	811	133	17	CID000005691
Drug	NSC611747	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 PPM1G MYO5C STK11 PRKCE	7.26e-06	352	133	11	CID000002534
Drug	MgCl2	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SPTB MYO18A MIB2 MYO5C	7.65e-06	354	133	11	CID000024584
Drug	2bq7	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	8.01e-06	123	133	7	CID006540267
Drug	AC1L9LMC	SYNE1 SPTB NUCB1 STX4 DST HRC	9.26e-06	83	133	6	CID000448113
Drug	AC1LADJ6	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	1.15e-05	130	133	7	CID000486032
Drug	carbachol	GPLD1 CACNA1B MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A TTC1 MYO5C ACIN1 PRKCE PLCD1	1.23e-05	688	133	15	CID000002551
Drug	AC1L1IZ2	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A SRPK1 MYO5C	1.23e-05	304	133	10	CID000004795
Drug	NSC226080	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A STAT5A STK11 SLC7A2 IGF2R FNIP1 PRKCE M6PR GOLGB1	1.36e-05	782	133	16	CID000005040
Drug	AC1NRBPQ	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11	1.62e-05	137	133	7	CID005288569
Drug	creatine	MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 SLC17A8	1.83e-05	193	133	8	CID000000586
Drug	Sulfadiazine [68-35-9]; Down 200; 16uM; MCF7; HT_HG-U133A	GIT1 NUMA1 PACSIN3 ZZEF1 GLI3 SEMA3B EXOC7 TJP3	1.97e-05	195	133	8	1688_DN
Drug	verapamil	CACNA1B MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A KL KCNE4 PRKCE	3.14e-05	490	133	12	CID000002520
Drug	nifedipine	CACNA1B MYH1 MYH2 MYH3 MYH4 MYH8 MYH10 MYH11 MYO18A PPM1G PRKCE	3.33e-05	415	133	11	CID000004485
Disease	myotonia congenita (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8 MSTO1	6.17e-12	12	131	6	DOID:2106 (implicated_via_orthology)
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	3.95e-10	10	131	5	DOID:0080326 (implicated_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	1.23e-09	12	131	5	DOID:11720 (implicated_via_orthology)
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	2.00e-09	13	131	5	DOID:397 (implicated_via_orthology)
Disease	distal arthrogryposis (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	4.63e-09	15	131	5	DOID:0050646 (implicated_via_orthology)
Disease	myopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	2.35e-06	48	131	5	DOID:423 (implicated_via_orthology)
Disease	cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	1.64e-05	71	131	5	DOID:0050700 (implicated_via_orthology)
Disease	dilated cardiomyopathy (implicated_via_orthology)	MYH1 MYH2 MYH3 MYH4 MYH8	2.94e-05	80	131	5	DOID:12930 (implicated_via_orthology)
Disease	hyperphosphatemic familial tumoral calcinosis (implicated_via_orthology)	KL GOLGB1	5.85e-05	3	131	2	DOID:0111063 (implicated_via_orthology)
Disease	Premature aging syndrome	ERCC6 KL	1.17e-04	4	131	2	C0231341
Disease	arthrogryposis multiplex congenita (is_implicated_in)	MYH8 SYNE1	1.17e-04	4	131	2	DOID:0080954 (is_implicated_in)
Disease	Malignant neoplasm of breast	MYH1 ERCC6 SYNE1 YY2 TACC2 STAT5A SRGAP3 FARP1 NLRC5 GPC2 ARRDC3 CLSPN ZNHIT2 GOLGB1	3.09e-04	1074	131	14	C0006142
Disease	cancer antigen 15.3 measurement	GON4L MSTO1	4.05e-04	7	131	2	EFO_0010585
Disease	Distal arthrogryposis	MYH3 MYH8	6.90e-04	9	131	2	cv:C0265213
Disease	amino acid measurement	MOXD2P MYH10 STAG1 SYNE1 TACC2 NCAPH2 SLC7A2 FARP1 PRKCE UNC5D	9.18e-04	678	131	10	EFO_0005134
Disease	Gastrointestinal Stromal Sarcoma	IFT172 GLI3 CC2D2A	1.20e-03	47	131	3	C3179349
Disease	complex trait	DMXL2 IFT172 FREM1 PPM1G STX4 NLRC5	1.36e-03	271	131	6	EFO_0010578
Disease	Gastrointestinal Stromal Tumors	IFT172 GLI3 CC2D2A	1.44e-03	50	131	3	C0238198
Disease	DEAFNESS, AUTOSOMAL RECESSIVE (disorder)	DMXL2 CDH23	1.48e-03	13	131	2	C1846647
Disease	body fat percentage	DMXL2 HIVEP1 STAG1 MIB2 ZZEF1 STX4 GADD45G SRGAP3	1.55e-03	488	131	8	EFO_0007800
Disease	cleft lip	SYNE1 IL20RA SLC7A2 KCNE4 DST GADD45G	1.73e-03	284	131	6	EFO_0003959
Disease	Drug habituation	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0013170
Disease	Drug abuse	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0013146
Disease	Prescription Drug Abuse	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C4316881
Disease	Substance-Related Disorders	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0236969
Disease	Drug Use Disorders	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0013222
Disease	Drug Dependence	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C1510472
Disease	Substance Dependence	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0038580
Disease	Substance Use Disorders	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0038586
Disease	Organic Mental Disorders, Substance-Induced	SYNE1 MYO5C FARP1 PRKCE	1.75e-03	115	131	4	C0029231
Disease	Peripheral Nervous System Diseases	CACNA1B PRKCE ALOX12	1.80e-03	54	131	3	C4721453
Disease	Substance abuse problem	SYNE1 MYO5C FARP1 PRKCE	1.81e-03	116	131	4	C0740858
Disease	facial morphology	MYO18A TTC34 UNC5D	1.90e-03	55	131	3	EFO_0004743
Disease	diacylglycerol 44:7 measurement	IFT172 PPM1G	2.25e-03	16	131	2	EFO_0020069
Disease	Congenital hernia of foramen of Morgagni	FREM1 IGF2R	3.18e-03	19	131	2	C0265699
Disease	Congenital hernia of foramen of Bochdalek	FREM1 IGF2R	3.18e-03	19	131	2	C0265700
Disease	Chronic myeloproliferative disorder	ATRIP PCNT	3.18e-03	19	131	2	C1292778
Disease	alpha-tocopherol measurement	PRKCE MRPL46	3.53e-03	20	131	2	EFO_0007898
Disease	mean corpuscular hemoglobin concentration	MYH2 DENND4A SPTB GON4L SRPK1 UBR5 ZNF638 CC2D2A PRKCE ARRDC3 CLSPN GOLGB1	3.83e-03	1105	131	12	EFO_0004528
Disease	Congenital diaphragmatic hernia	FREM1 IGF2R	3.89e-03	21	131	2	C0235833
Disease	skin hydration measurement	MKNK2 IYD	3.89e-03	21	131	2	EFO_0009586
Disease	Stomach Carcinoma	STK11 UBR5	3.89e-03	21	131	2	C0699791
Disease	Arthrogryposis	MYH3 ERCC6	3.89e-03	21	131	2	C0003886
Disease	body weight	CACNA1B HIVEP1 GON4L TTC1 ZZEF1 RALY KCNE4 ZNF638 FNIP1 PRKCE MGA M6PR PDZD2	4.08e-03	1261	131	13	EFO_0004338
Disease	Seckel syndrome	ATRIP PCNT	4.26e-03	22	131	2	C0265202
Disease	Attention Deficit Disorder	GIT1 ADGRL3	4.26e-03	22	131	2	C0041671
Disease	Minimal Brain Dysfunction	GIT1 ADGRL3	4.26e-03	22	131	2	C1321905

Protein segments in the cluster

Peptide	Gene	Start	Entry
LAGQEAVVDLHADDS	ACIN1	881	Q9UKV3
EQDDEDDLSAGLALI	BUB1	931	O43683
LDDEEFALASHLIEA	EHD2	501	Q9NZN4
EESLGLELIHEESDA	ADGRL3	1291	Q9HAR2
LSAGVDVGNHDEDLD	CACHD1	1216	Q5VU97
EEDFHPELESLDGDL	GIT1	621	Q9Y2X7
DHEAFLDVLDNDGRT	ANKRD35	141	Q8N283
DHDSALDEEEDDAVG	DMXL2	1981	Q8TDJ6
LVHDSGDAEDEENDI	ELP6	181	Q0PNE2
DVADVLLQAGADLEH	ANKRD17	611	O75179
DITHDIEALAPDDDD	CCM2L	536	Q9NUG4
SLEGHLRDENNEEDA	SLC7A2	606	P52569
ALLEEEDASEQDIHL	CASP8AP2	1481	Q9UKL3
EDASEQDIHLALESD	CASP8AP2	1486	Q9UKL3
TEGDEEAAAILEHLE	C1orf115	26	Q9H7X2
NDLIHAEEGEDRFAD	CACNA1B	426	Q00975
ELAAQAEHEDDLPEN	CDH23	3141	Q9H251
AEHEDDLPENLSEIA	CDH23	3146	Q9H251
ELIQTELDEEPGDHS	CDH23	3246	Q9H251
IELDHASLEEDAEPG	ERCC6	206	Q03468
DILIGHERDDDNSEE	ARRDC3	86	Q96B67
LERIAAEEEEENDGH	ATG2B	861	Q96BY7
ELESLLENEGDHAIT	DENND4A	1646	Q7Z401
ELEHSQDTDADDGAL	RALY	291	Q9UKM9
LDTDHDLLIDADDLA	PPP2R3B	326	Q9Y5P8
HGRNSDLSDIQEEEE	TSPOAP1	1251	O95153
EELLNGHASDSENED	IWS1	136	Q96ST2
EDEASLEDALDHLAF	P4HA3	221	Q7Z4N8
IELDHASLEEDAEPG	ERCC6	206	P0DP91
HLTIQEEGADDELEE	KCNE4	186	Q8WWG9
VDSLDSHDLEGVQID	GLI3	1491	P10071
NEDILHSEEATLDSG	DYDC1	126	Q8WWB3
DIDIDSLEADSHLDE	MTIF2	121	P46199
LNDSLEDRGDHLDEE	MGA	2021	Q8IWI9
LGHDLDGQDADEDAS	GPC2	486	Q8N158
LFEDDDHDSLLLDGD	DST	2406	Q03001
DHDSLLLDGDDRDCL	DST	2411	Q03001
NEDDLFESILHDDVL	PRKCE	611	Q02156
LSELLSHEGNVEEDF	HECTD2	566	Q5U5R9
EQDELEQELLEHGRD	C3orf18	106	Q9UK00
ALEEAEASLEHEEGK	MYH8	1546	P13535
LAQHDEDLAEEEAAG	MKNK2	406	Q9HBH9
AGVEHDDVAELLQEL	MSTO1	541	Q9BUK6
KLDHDGAILDVDEDD	MYO18A	381	Q92614
LQAALEEAEASLEHE	MYH2	1546	Q9UKX2
VNGLEHDLLDDETLN	PDZD2	1731	O15018
QHDGTEVLQDDLLLE	FREM1	851	Q5H8C1
AALEEAEASLEHEEG	MYH1	1546	P12882
EEEFDHDVAEDLGLL	ALOX12	46	P18054
LHDINSDGVLDEQEL	NUCB1	251	Q02818
EDLQSEHGRCLEDLE	PCNT	421	O95613
GDDDLEAQEDVTLEH	EXOC7	176	Q9UPT5
DLDPLAQEHTDSEEG	IL20RA	456	Q9UHF4
HLEEVDLSGNQLEDE	NLRC5	871	Q86WI3
TLDGLDHSDFQDTDI	IFT172	1611	Q9UG01
DFLTLHGLQDDEDLQ	PLCD1	6	P51178
ATVLDQEDDDDGHLL	HECTD1	581	Q9ULT8
QEDDDDGHLLALQII	HECTD1	586	Q9ULT8
NGDDAEDFLLGLDHV	CC2D2A	246	Q9P2K1
QFLDLLAGDEEEHAV	CC2D2A	1356	Q9P2K1
KSQGEDVEDDHRAEL	CC2D2A	1536	Q9P2K1
QSAGDHLEEELDLLL	AVEN	276	Q9NQS1
SEIGDFDEALDREHL	FARP1	166	Q9Y4F1
LSEHEEGSLLEENFG	FBXO5	156	Q9UKT4
EEDEGDIALQIHFTL	GADD45G	66	O95257
SELQETHLLENGEDE	FNIP1	546	Q8TF40
DDEVHDAALNLRLED	COL6A5	351	A8TX70
QLSDHGDLLSEEELD	GON4L	2226	Q3T8J9
HDGHDDDVIDIEDDL	CANX	21	P27824
ELESLLENEGDQVIH	DENND4C	1696	Q5VZ89
SDRQEEEGLEFLDHL	DSC1	866	Q08554
ISNGIDDGLHAEDDQ	KL	871	Q9UEF7
AHGDFTADDLEELDT	ATRIP	51	Q8WXE1
DLSSDDDLPHDEEAL	CAVIN2	201	O95810
HIQDLEEQLDEEEGA	MYH10	951	P35580
LHLEGASLELSDDDT	MYH10	1946	P35580
DHEDGLNLNEDLENF	NUMA1	136	Q14980
RDLHQGIEAASDEED	PACSIN3	266	Q9UKS6
EDLKDSSDLHQAEED	IYD	46	Q6PHW0
AEDEEGDTALHVALQ	MIB2	696	Q96AX9
EEDLHETQVGSLNDA	RP1	1001	P56715
SDQHLVEEDTLKEDG	MOXD2P	96	A6NHM9
DLAIDGADEVDADLN	RPIA	156	P49247
SLHGDDQDSEDEVLT	IGF2R	2401	P11717
DVAEERDNGESEAHE	RSPH4A	386	Q5TD94
HDEEDEQDILLAQDL	MRPL46	106	Q9H2W6
HEGLDIIENAVDNLE	SRGAP1	296	Q7Z6B7
DDDSDLILNDGDISL	SLC9A6	586	Q92581
EDALDRELAFGDHEL	SLC9A6	626	Q92581
ADLEHSLAELSELDG	SYNE1	4961	Q8NF91
DLSDDREELLHGISE	TCAF1	211	Q9Y4C2
DVDNEEAALLHEEAT	PPM1G	136	O15355
DPAEELHEAEQELLS	SMIM29	61	Q86T20
HEGLDAIENAVENLD	SRGAP2B	306	P0DMP2
DTQLHLDDAIRGQDD	MYH4	1656	Q9Y623
IQLALEEAEAALEHE	MYH3	1541	P11055
DHETDGDLLAETDVL	MYCBP2	1291	O75592
LEDLHGADEDEDLFD	STK11	341	Q15831
AEQPDGIIDDSLHLE	SLF2	1066	Q8IX21
HELRQGDDSSDEEDK	STX4	6	Q12846
QEDEEDEEEGHGLSL	HRC	516	P23327
DEEEGHGLSLNQEEE	HRC	521	P23327
HSESDLPEQEEEILG	SRPK1	36	Q96SB4
QSADEEAIAELLDEH	MTRF1	426	O75570
LSLNRGDEDEDDHED	NOL4	376	O94818
NPDHVLDQDGEFDLD	STAT5A	741	P42229
DGARLEGDLSLAHED	AHNAK2	4606	Q8IVF2
ELEETRELAGQHEDD	CCDC136	71	Q96JN2
RELAGQHEDDSLELQ	CCDC136	76	Q96JN2
QHEDDSLELQGLLED	CCDC136	81	Q96JN2
EEDHLEDSLEDLGAA	NCAPH2	421	Q6IBW4
EHSDSGNDLALEDHE	CLSPN	1016	Q9HAW4
GNDLALEDHEDDDEE	CLSPN	1021	Q9HAW4
LEGHISDLQEDLDSE	MYH11	1116	P35749
INHGETSDETLLEDA	UCHL3	191	P15374
DQLGEESEERDDHLL	M6PR	261	P20645
GHILEEFATLQDEAE	NAA35	451	Q5VZE5
HEGLDVIENAVDNLD	SRGAP3	296	O43295
DLGSGDSQEDHLQIE	STAG3	851	Q9UJ98
DHSNNDRLEGAEIEE	PLCD3	231	Q8N3E9
AEGLLLEELHVFEDS	SEMA3B	471	Q13214
AADIDHKLEEQLIDG	SF3B1	881	O75533
LEDQLALPDSIEDEH	YY2	101	O15391
VLHLSDLDDDGLDEI	GPLD1	721	P80108
HSVEDLLQEGEEADD	STAG1	671	Q8WVM7
ALADALEEGSQHEEA	TACC2	996	O95359
DAHRLLSGEDVGQDE	SPTB	761	P11277
HDGDLDSLACALEEI	UNC5D	911	Q6UXZ4
IASLEKDLEEQDGHD	UNKL	431	Q9H9P5
DGATSDDLDLHDDRL	TJP1	806	Q07157
AEDQLDGSLEDNLDL	TJP3	771	O95049
EEALQAAAHVLEAGE	ZNHIT2	261	Q9UHR6
GELFSDSEDLDGHLE	ZNF496	441	Q96IT1
DSEDLDGHLESHEAQ	ZNF496	446	Q96IT1
EINALAEHGDLELDE	ZZEF1	2416	O43149
SREILDHQDGNVEDD	USP34	1771	Q70CQ2
LRDDEAHLQEDQGEE	TTC1	46	Q99614
DLDHVLQEALGDGDL	TTC34	446	A8MYJ7
EDNDHLQLSAEVVEG	PJA2	176	O43164
EEEGATDERQHDLGA	HIVEP1	496	P15822
LDEIGEEEDAAAHLA	ZNF638	1601	Q14966
LHLELGQEEAELEEF	TBC1D2	166	Q9BYX2
LELGIDNEDSEHEND	UBR5	1981	O95071
DELAEEIELNHESFA	SLC17A8	526	Q8NDX2
VVLHELSGDDDTDQN	GOLGB1	11	Q14789
SHGESSAELDEQDIL	NACAD	1371	O15069
SRLSVEDLEHLNEDG	MYO5C	1121	Q9NQX4
DLSGLTDDETEHVLQ	MYRIP	6	Q8NFW9